MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$124,395K
Net Income
$37,822K
Net Profit Margin
30.40%
EPS
$0.16
Unit: Thousand (K) dollars
Revenue Breakdown
ASCENIV
BIVIGAM
Intermediates And Other
Others
Revenue Breakdown
Operating Segments
Revenue From Contract With Custo...
Material Reconciling Items
Revenue Breakdown
ADMABio Manufacturing Segment
Plasma Collection Centers Segmen...
Material Reconciling Items
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenues
124,395
114,493
139,163
134,224
Cost of product revenue
38,118
33,743
50,348
58,598
Gross profit
86,277
80,750
88,815
75,626
Research and development
6,014
2,597
1,377
1,528
Plasma center operating expenses
1,026
1,062
1,126
1,272
Amortization of intangible assets
55
55
49
38
Gain on sale of plasma centers
0
7,980
-
-
Selling, general and administrative
26,737
26,742
23,511
21,776
Total operating expenses
33,832
22,476
26,063
24,614
Income from operations
52,445
58,274
62,752
51,012
Interest income
-
-
487
376
Interest and other income
1,238
1,093
-
-
Interest expense
3,424
2,100
1,626
1,675
Gain on extinguishment of debt
0
-
0
-2,177
Other expense
-22
-140
-19
-21
Other income (expense), net
-2,208
-1,147
-1,158
-3,497
Income before income taxes
50,237
57,127
61,594
47,515
Provision for income taxes
12,415
11,799
12,215
11,087
Net income
37,822
45,328
49,379
36,428
Basic EPS
0.17
0.19
0.21
0.15
Diluted EPS
0.16
0.19
0.204
0.15
Basic Average Shares
228,232,503
236,072,751
235,326,927
238,602,978
Diluted Average Shares
230,337,048
239,955,762
241,669,487
244,664,263
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
3
ASCENIV
$102,921K
BIVIGAM
$19,419K
Intermediates And Other
$1,297K
ADMABio Manufacturing
Segment
$123,637K
Plasma Collection
Centers Segment
$723K
Material Reconciling
Items
$35K
(-2.78%↓ Y/Y)
Revenues
$124,395K
(1.98%↑ Y/Y)
Gross profit
$86,277K
(28.34%↑ Y/Y)
Cost of product
revenue
$38,118K
(-30.39%↓ Y/Y)
Income from operations
$52,445K
(22.54%↑ Y/Y)
Total operating
expenses
$33,832K
(38.49%↑ Y/Y)
Income before income
taxes
$50,237K
(25.29%↑ Y/Y)
Other income
(expense), net
-$2,208K
(18.25%↑ Y/Y)
Interest and other income
$1,238K
Selling, general and
administrative
$26,737K
(20.36%↑ Y/Y)
Research and development
$6,014K
(483.32%↑ Y/Y)
Plasma center
operating expenses
$1,026K
(-10.94%↓ Y/Y)
Amortization of intangible
assets
$55K
(71.88%↑ Y/Y)
Net income
$37,822K
(10.53%↑ Y/Y)
Provision for income taxes
$12,415K
(111.21%↑ Y/Y)
Interest expense
$3,424K
(86.70%↑ Y/Y)
Other expense
-$22K
(79.63%↑ Y/Y)
Buy us a coffee
ADMA logo-svg
ADMA BIOLOGICS, INC. (ADMA)
ADMA logo-svg
ADMA BIOLOGICS, INC. (ADMA)